State of secondary prevention in Czech coronary patients in the EUROASPIRE IV study

Among coronary patients, prevalence of overweight, obesity, and diabetes increased. Although pharmacotherapy is used in a majority of secondary prevention in patients, the recommended levels of blood pressure, lipid, and glucose metabolism are largely not achieved. Also, implementation of non-pharmacologic interventions of lifestyle factors remains unsatisfactory.